Product Categories
| Country: | China |
|---|---|
| Tel: | 028-64841719 |
| Mobile: | 15680023009 |
| E-mail: | daisy@enlaibio.com |
| QQ: | 2777524105 |
| Skype: | Chat Now! |
| Address: | A38-2, No. 66, Nanhu road, Deyang City, Sichuan Province (Jiuwei Blue Valley) |
|
Sichuan HongRi Pharma-Tech Co.,Ltd(Enlai Biotech)is a high-tech technology enterprise approved by the Chengdu Municipal Government and is a private enterprise specializing in the development,production and sales of natural amino acids,non-natural amino acids,amino acid derivatives,peptides,pharmaceutical intermediates,pharmaceutical raw materials and raw pharmaceutical.
We have a professional and experienced R&D and production management team composed by returnees,MD,MS,university professors,and senior engineers who have rich experience in industry practices.We use different models of production equipment(specification coverage:gram to ton),standard R&D lab and workshop,comprehensive detecting instruments and equipment(including:HPLC,GC,HNMR,etc.)and efficient management system to ensure the best product quality.Our products are widely accepted and appreciated by not only domestic industry institutes and enterprises,but also those in Europe and US.
Our philosophy: Innovation, Honesty and Integrity, Contribute to the present society and later ages. Our aim: people-oriented, common development. We are working hard to provide a good platform and development space for employees, and to best fit the customers'needs with high quality and valued products. We are sincerely willing to work with you to development, go hand in hand and create brilliant future!
|
|
| Product Name | MF | CAS | Details |
|---|
| Regorafenib impurity | C14H9ClF4N2O2 | 2243399-56-4 | Details |
| EZLA-ZZC-0/EZLA-S1 | C8H7BrFNO | 749927-69-3 | Details |
| 4-amino-2-fluoro-N-methylbenzamide | C8H9FN2O | 915087-25-1 | Details |
| SL-CLYG;Sorafenib related coMpound 8 | C21H16ClF3N4O3 | 1431697-81-2 | Details |
| 4-(Isopropylamino)-2-(trifluoromethyl)benzonitrile | C11H11F3N2 | 864286-45-3 | Details |
| METHOXY-PHENYL-ACETIC ACID METHYL ESTER | C10H12O3 | 3558-61-0 | Details |
| API-ZA01/M2-2J | C27H22F2N6O5 | 2438857-80-6 | Details |
| Ethyl alpha-Formyl Benzeneacetic Acid Ester | C11H12O3 | 17838-69-6 | Details |
| EZ-SJ-COOH | Details |
| 3-methoxy-3-oxo-2-phenylpropanoic acid | C10H10O4 | 33315-63-8 | Details |
| SM3-ZA02/RG-D;Regorafenib iMpurity | C14H9ClF4N2O2 | 1333390-56-9 | Details |
| Regorafenib impurity H | C15H14FN3O3 | 2141961-84-2 | Details |
| 2-CHLORO-6-(TRIFLUOROMETHYL)PHENYL | C8H3ClF3NO | 16583-76-9 | Details |
| Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate | C17H19N3O4 | 2206827-14-5 | Details |
| API-ZA07;3,4-BIS CTF- CARBOMYLAMINE PMA REGORAFENIB | C35H23Cl2F7N6O5 | 2098799-13-2 | Details |
| 2-Pyridinecarboxamide, 1,4-dihydro-N-methyl-4-oxo- | C7H8N2O2 | 1061231-84-2 | Details |
| Apalutamide Impurity 44 | C21H14F4N4O3S | 1950587-19-5 | Details |
| APOATROPINE | C17H21NO2 | 500-55-0 | Details |
| 2-Pyridinecarboxamide,N-methyl-(9CI) | C7H8N2O | 6144-78-1 | Details |
| Benzoic acid, 4-[[2-[[4-cyano-3-(trifluoromethyl)phenyl]amino]-1,1-dimethyl-2-oxoethyl]amino]-2-fluoro-, ethyl ester | C21H19F4N3O3 | 2463603-98-5 | Details |
| D3-EZ-M1-FA | Details |
| APLA-COOH | C20H12F4N4O3S | 1332391-04-4 | Details |
| 2-fluoro-4-hydroxy-N-methylbenzamide | C8H8FNO2 | 1243392-80-4 | Details |
| YB-YS1;Atropine Impurity 4 | C17H23NO3 | 3423-23-2 | Details |
| RG-491; INDEX NAME NOT YET ASSIGNED | C25H19F2N5O4 | 2518234-85-8 | Details |
| 4-(4-Aminophenoxy)-N-methylpicolinamide | C13H13N3O2 | 284462-37-9 | Details |
| 8-Azabicyclo[3.2.1]octan-3-ol,8-(1-methylethyl)-(9CI) | C10H19NO | 259092-15-4 | Details |
| Atropic acid | C9H8O2 | 492-38-6 | Details |
| Regorafenib;BAY 73-4506 | C21H15ClF4N4O3 | 755037-03-7 | Details |
| Tropic acid | C9H10O3 | 529-64-6 | Details |
| 4-(4-(3-(4-chloro-3-(trifluoroMethyl)phenyl)ureido)-3-fluorophenoxy)-2-(MethylcarbaMoyl)pyridine 1-oxide | C21H15ClF4N4O4 | 835621-11-9 | Details |
| Sorafenib Impurity 6 | C21H17F3N4O3 | 1285533-84-7 | Details |
| 4-bromo-N-methylpicolinamide | C7H7BrN2O | 1209459-88-0 | Details |
| AI-ZA04;4-Chloro-alpha,alpha,alpha-trifluoro-m-toluidine | C7H5ClF3N | 320-51-4 | Details |
| Atropine Impurity 5 | C18H25NO2 | 88607-15-2 | Details |
| YB-S2-COOH;Anisodine Impurity 4 | C9H8O3 | 59216-85-2 | Details |
| ETHYL 4-CHLORO-3-TRIFLUOROMETHYLCARBANILATE | C10H9ClF3NO2 | 18585-06-3 | Details |
| YB-S2;METHYL A-FORMYLPHENYLACETATE | C10H10O3 | 5894-79-1 | Details |
| Sorafenib impurity N/1-(4-chloro-3-(trifluoromethyl)phenyl)urea | C8H6ClF3N2O | 343247-69-8 | Details |
| 2-fluoro-N,N-dimethyl-4-nitro-benzamide | C9H9FN2O3 | 1187368-66-6 | Details |
| Acetamide,N-(2-fluoro-4-hydroxyphenyl)- | C8H8FNO2 | 103842-00-8 | Details |
| N-methyl-4-phenoxypyridine-2-carboxamide | C13H12N2O2 | 2004659-85-0 | Details |
| AP-M1 | C13H15FN2O3 | 2227589-22-0 | Details |
| YB-YM2; Ipratropium Bromide Impurity 12 | C20H29Br2NO3 | 60233-19-4 | Details |
| Sorafenib impurity 16/Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate | C16H17N3O4 | 2206827-12-3 | Details |
| YB-YM1;8-isopropyl-8-azabicyclo[3.2.1]oct-3-yl endo-(±)-formylphenylacetate | C19H25NO3 | 22235-74-1 | Details |
| 2-Fluoro-4-Hydroxyaniline | C6H6FNO | 1009816-75-4 | Details |
| D3-EZ-FA | Details |
| 4-(4-AMINO-3-FLUOROPHENOXY)-N-METHYLPICOLINAMIDE | C13H12FN3O2 | 757251-39-1 | Details |
| YB-ZZF;IpratropiuM BroMide IMpurity F (Mixture of DiastereoMers) | C20H29Br2NO3 | 17812-46-3 | Details |
| AP-API-XA | C20H13F4N5O2S | 1332391-11-3 | Details |
| 4-CHLORO-N,N-DIMETHYL-PYRIDINE-2-CARBOXAMIDE | C8H9ClN2O | 114780-06-2 | Details |
| Benzene, 2-chloro-4-isocyanato-1-(trifluoromethyl)- | C8H3ClF3NO | 39893-50-0 | Details |
| Regorafenib impurity | C22H12Cl2F7N3O3 | 2518416-73-2 | Details |
| Noratropine | C16H21NO3 | 16839-98-8 | Details |
| Methyl 4-bromo-2-fluorobenzoate | C8H6BrFO2 | 179232-29-2 | Details |
| DL-TROPIC ACID | C9H10O3 | 552-63-6 | Details |
| 6-Chloro-N-methylpyridine-2-carboxamide | C7H7ClN2O | 845306-04-9 | Details |
| Ethyl Tropic Acid | C11H14O3 | 3979-14-4 | Details |
| RG-368;Regorafenib Impurity 10 | C19H17FN4O3 | 2098799-12-1 | Details |
| Regorafenib Impurity 13 | C14H14N2O | 2909-32-2 | Details |
| Sorafenib Impurity 6 | C27H23N5O6 | 2204442-52-2 | Details |
| AP-API-YH | C21H15F4N5O3 | 1332391-92-0 | Details |
| AP-S4-SXA | C8H5F3N4S | 2422147-84-8 | Details |
| 1,2-dimethylpiperidine | C7H15N | 671-36-3 | Details |
| Benzamide, 4-[[[[4-cyano-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-2-fluoro-N-methyl- | C17H12F4N4O2 | 1351185-73-3 | Details |
| 2-Pyridinecarboxamide, 4-chloro-N-(2-fluoro-4-hydroxyphenyl)- | C12H8ClFN2O2 | 1798046-84-0 | Details |
| APLA-M2-COOH | C12H12FNO4 | 2819997-98-1 | Details |
| 4-Bromo-2-fluorobenzoic acid | C7H4BrFO2 | 112704-79-7 | Details |
| N-Desmethyl Regorafenib N-Oxide (M5 Metabolite) | C20H13ClF4N4O4 | 835621-12-0 | Details |
| TICAGRELOR | C14H14N4O3 | 1129683-88-0 | Details |
| SL-M2-2J;Sorafenib Impurity 3 | C27H24N6O5 | 284670-98-0 | Details |
| 4-CHLORO-2-FLUORO-N-METHYLBENZAMIDE | C8H7ClFNO | 1343038-33-4 | Details |
| Methyl (4-chloro-3-trifluoromethylphenyl)carbamate | C9H7ClF3NO2 | 19448-54-5 | Details |
| VORSMCHHJRVORT-UHFFFAOYSA-N | C19H27NO3 | 793603-45-9 | Details |
| SL-M2-TA-COOH;4-phenoxypyridine-2-carboxylic acid | C12H9NO3 | 99970-10-2 | Details |
| AP-417 | C52H79NO14 | 1237826-25-3 | Details |
| Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide | C20H19N5O3 | 2004659-83-8 | Details |
| AP-435 | C20H17F4N5O2 | 1950587-20-8 | Details |
| RG-S1-XA; 4-Chloropyridine-2-carboxamide | C6H5ClN2O | 99586-65-9 | Details |
| ATP-M1;Benzeneacetic acid, α-formyl-, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester | C17H21NO3 | 22226-37-5 | Details |
| (endo,anti)-(±)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide | C20H30BrNO3 | 58073-59-9 | Details |
| Carbamothioic acid, N-[4-cyano-3-(trifluoromethyl)phenyl]-, O-ethyl ester | C11H9F3N2OS | 2088914-59-2 | Details |
| A-(HYDROXYMETHYL)BENZENACETIC ACID METHYL ESTER | C10H12O3 | 3967-53-1 | Details |
| D3-EZLA-ZZF/EZLA-ZZI | Details |
| N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-(4-hydroxyphenyl)urea | C14H10ClF3N2O2 | 1129683-83-5 | Details |
| CPI-203 | C8H3ClF3NO | 88330-63-6 | Details |
| 2-Aminophenol | C6H7NO | 95-55-6 | Details |
| 2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL | C8H3ClF3NO | 51488-22-3 | Details |
| Ipratropium Bromide EP Impurity F Bromide | C20H28BrNO2 | 60018-35-1 | Details |
| Regorafenib Impurities67 | C16H16FN3O4 | 2514957-39-0 | Details |
| 8-isopropyl-8-azabicyclo[3.2.1]octan-3-one | C10H17NO | 3423-28-7 | Details |
| EZ-S1-TJZZ | Details |
| 4-CYANO-3-(TRIFLUOROMETHYL)ACETANILIDE | C10H7F3N2O | 97760-99-1 | Details |
| Ipratropium bromide monohydrate | C20H32BrNO4 | 66985-17-9 | Details |
| 5-AMINO-3-(TRIFLUOROMETHYL)PICOLINONITRILE | C7H4F3N3 | 573762-62-6 | Details |
| Urea, N'-[4-chloro-3-(trifluoromethyl)phenyl]-N,N-dimethyl- | C10H10ClF3N2O | 2711-18-4 | Details |
| ATROPINE METHYL BROMIDE | C18H26BrNO3 | 2870-71-5 | Details |
| Benzamide, N-[[[4-cyano-3-(trifluoromethyl)phenyl]amino]thioxomethyl]- | C16H10F3N3OS | 1895865-08-3 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 | ||||